Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
2025 Standout
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
2025 Standout
3 intermediate papers

Works of Tulin Shekar being referenced

Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE)
2022
Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Tulin Shekar 142 87 65 89 33 238
Kazuhiro Hashiguchi 129 37 36 152 35 295
Meiping Lu 105 29 45 104 33 263
Marcela Valverde‐Monge 76 78 28 31 28 191
Ryuichi Takenaka 84 124 62 45 24 289
Jin Tack Kim 66 42 27 45 22 160
Hirotaka Yasuba 143 87 23 70 27 229
David Costa 109 69 11 80 32 269
Wirach Chitsuthipakorn 145 40 14 174 30 295
H. Luckhaupt 59 63 41 62 31 297
Masaki Hayama 124 37 21 108 39 264

All Works

Loading papers...

Rankless by CCL
2026